NeOnc Breaks Through Key Levels, as Brain-Cancer Stock’s Catalysts Continue
A paid 24/7 Market News editorial highlights NeOnc's technical breakout above $3 and a reported 45.1% rise in short interest to 757,739 shares. The piece recaps an October 21 MOU with the Department of Health-Abu Dhabi and two children receiving investigational NEO100 through a Compassionate Care program.
Key figures
- Technical level broken
- $3
- Avg analyst price target
- $17
- Short interest change pct
- 45.1%
- Short interest shares sep15
- 522311
- Short interest shares sep30
- 757739
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.